Table 6.
Current contraceptive use in the United States—conventional modality survey (CMS) and app-based samples compared with the 2020 US National Survey of Family Growth (NSFG) 2017 to 2019 [38].
| Responses | CMS sample (n=2464), n (%) | App-based sample (n=10,244), n (%) | NSFG (aged 15-49 years, % of sample) | ||||||
| Current contraceptive users | 1778 (72.2a,b) | 7748 (75.6a,b) | Weighted %c (47a) | ||||||
|
|
Hormonal methods (total) | 1184 (66.6c) | 3033 (39.1c,d) | 60c (28.4a) | |||||
|
|
|
LARCe methods | 421 (23.7c) | 1216 (15.7c) | 26c (12.4a) | ||||
|
|
|
|
IUDf or IUSg | 192 (10.8c,d) | 827 (10.7c,d) | 18c (8.4a) | |||
|
|
|
|
Injection | 143 (8c) | 43 (0.6c) | 4c (2a) | |||
|
|
|
|
Implant | 86 (4.8c) | 346 (4.5c) | 4c (2a) | |||
|
|
|
Non-LARC methods | 763 (42.9c) | 1757 (22.5c) | 34c (16a) | ||||
|
|
|
|
Pill | 763 (42.9b,c) | 1586 (20.5c,d) | 30c (14a) | |||
|
|
|
|
Ring or patch | 0 (0) | 171 (2.2c) | 4c (2a) | |||
|
|
Morning-after pill | 24 (1.3c) | 60 (0.8c) | N/Ah | |||||
|
|
Nonhormonal methods (total) | 570 (32.1c) | 4147 (53.5b,c) | 29c (13.8a) | |||||
|
|
|
Condoms | 354 (19.9)c | 1894 (24.4)c | 18c (8.4a) | ||||
|
|
|
Natural methods | 128 (7.2)c | 1598 (20.6)b,c | 11c (5.4a) | ||||
|
|
|
Copper IUD | 31 (1.7)c | 655 (8.5)c | 0 (0) | ||||
|
|
|
Other methods | 57 (3.2c,d) | 568 (7.3)c,d | 12c (5.6a) | ||||
| Other responses | 686 (27.8a) | 2496 (24.4a) | 53a | ||||||
|
|
None used in the last 3 months | 510 (20.7a,d) | 1688 (16.5)a,d | 34.7a | |||||
|
|
Female sterilization | N/A | N/A | 18a | |||||
|
|
No answer or N/A | 176 (7.1a) | 808 (7.9a) | N/A | |||||
aPercentage of survey sample.
bOverrepresentation compared with benchmark.
cPercentage of current contraceptive users (samples do not include sterilized respondents).
dUnderrepresentation compared with benchmark.
eLARC: long-acting reversible contraception.
fIUD: intrauterine device.
gIUS: intrauterine system.
hN/A: not applicable.